Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis

Abstract

The present study suggests that a selective CB(2) agonist could be a new therapy for RA that inhibits production of inflammatory mediators from FLS, and osteoclastogenesis.